The Role of Advanced Generation Macrolides in the Prophylaxis and Treatment of Mycobacterium avium Complex (MAC) Infections
- 1 July 1997
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 54 (1) , 69-80
- https://doi.org/10.2165/00003495-199754010-00006
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A Randomized Trial of Clarithromycin as Prophylaxis against DisseminatedMycobacterium aviumComplex Infection in Patients with Advanced Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1996
- Pharmacokinetics of clarithromycin and zidovudine in patients with AIDSAntimicrobial Agents and Chemotherapy, 1995
- Clarithromycin Therapy for BacteremicMycobacterium aviumComplex DiseaseAnnals of Internal Medicine, 1994
- Low Serum Levels of Oral Antimycobacterial Agents in Patients with Disseminated Mycobacterium avium Complex DiseaseThe Journal of Infectious Diseases, 1993
- Mycobacterium avium strains resistant to clarithromycin and azithromycinAntimicrobial Agents and Chemotherapy, 1993
- Recommendations on Prophylaxis and Therapy for Disseminated Mycobacterium avium Complex Disease in Patients Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1993
- The Mycobacterium avium complexClinical Microbiology Reviews, 1993
- Tuberculosis And Nontuberculous Mycobacterial DiseaseMedical Clinics of North America, 1992
- Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450Antimicrobial Agents and Chemotherapy, 1991
- Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991